Cargando…

Prolyl 4-hydroxylase subunit beta (P4HB) could serve as a prognostic and radiosensitivity biomarker for prostate cancer patients

BACKGROUND: Prolyl 4-hydroxylase subunit beta (P4HB) has been reported as a suppressor in ferroptosis. However, no known empirical research has focused on exploring relationships between P4HB and prostate cancer (PCa). In this research, we initially examine the function of P4HB in PCa by thorough an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Feng, Dechao, Li, Li, Li, Dengxiong, Wu, Ruicheng, Zhu, Weizhen, Wang, Jie, Ye, Luxia, Han, Ping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10362756/ https://www.ncbi.nlm.nih.gov/pubmed/37480146 http://dx.doi.org/10.1186/s40001-023-01215-2

Ejemplares similares

Spindle and kinetochore-associated complex subunit 3 could serve as a prognostic biomarker for prostate cancer
por: Feng, Dechao, et al.
Publicado: (2022)

Identification of senescence-related lncRNA prognostic index correlating with prognosis and radiosensitivity in prostate cancer patients
por: Feng, Dechao, et al.
Publicado: (2023)

Endoplasmic reticulum chaperone prolyl 4-hydroxylase, beta polypeptide (P4HB) promotes malignant phenotypes in glioma via MAPK signaling
por: Sun, Stella, et al.
Publicado: (2017)

Thrombospondin-1 and prolyl 4-hydroxylase subunit alpha 3 as potential biomarkers of salivary gland fibrosis
por: Zhang, Zijian, et al.
Publicado: (2023)

High expression of prolyl 4-hydroxylase subunit alpha-2 in lung adenocarcinoma indicates poor prognosis
por: Lu, Xiao-Hong, et al.
Publicado: (2022)

Prolyl-4-hydroxylase α subunit 2 promotes breast cancer progression and metastasis by regulating collagen deposition
por: Xiong, Gaofeng, et al.
Publicado: (2014)

Prolyl 4 Hydroxylase: A Critical Target in the Pathophysiology of Diseases
por: Kant, Ravi, et al.
Publicado: (2013)

An Arabidopsis Prolyl 4 Hydroxylase Is Involved in the Low Oxygen Response
por: Konkina, Anna, et al.
Publicado: (2021)

Prolyl-4-Hydroxylase α Subunit 2 as a Novel Potential Biomarker for Predicting the Prognosis of Epithelial Ovarian Carcinoma
por: Zhang, Haibo, et al.
Publicado: (2021)

Collagen Type X Alpha 1 (COL10A1) Contributes to Cell Proliferation, Migration, and Invasion by Targeting Prolyl 4-Hydroxylase Beta Polypeptide (P4HB) in Breast Cancer
por: Yang, Weibin, et al.
Publicado: (2021)

Sandwich ELISA for quantitative detection of human collagen prolyl 4-hydroxylase
por: Osmekhina, Ekaterina, et al.
Publicado: (2010)

Studies on spiro[4.5]decanone prolyl hydroxylase domain inhibitors
por: Holt-Martyn, James P., et al.
Publicado: (2019)

Scientific Advancements in Drug Development and Trials for Urothelial Carcinoma: Insights From the 2023 ASCO-GU Cancers Symposium
por: Feng, Dechao, et al.
Publicado: (2023)

High Prolyl 4-Hydroxylase Subunit Alpha 3 Expression as an Independent Prognostic Biomarker and Correlated With Immune Infiltration in Gastric Cancer
por: Niu, Xiaoji, et al.
Publicado: (2022)

Function and expression of prolyl hydroxylase 3 in cancers
por: Liu, Qiu-long, et al.
Publicado: (2013)

Prognostic value of hypoxia-inducible factor-1 alpha and prolyl 4-hydroxylase beta polypeptide overexpression in gastric cancer
por: Zhang, Jun, et al.
Publicado: (2018)

Transmembrane Prolyl 4-Hydroxylase is a Novel Regulator of Calcium Signaling in Astrocytes
por: Byts, Nadiya, et al.
Publicado: (2021)

Targeted Inhibition of P4HB Promotes Cell Sensitivity to Gemcitabine in Urothelial Carcinoma of the Bladder
por: Wang, Xiaoming, et al.
Publicado: (2020)

Complement C1q is hydroxylated by collagen prolyl 4 hydroxylase and is sensitive to off-target inhibition by prolyl hydroxylase domain inhibitors that stabilize hypoxia-inducible factor
por: Kiriakidis, Serafim, et al.
Publicado: (2017)

Prolyl-4-hydroxylase Α subunit 2 (P4HA2) expression is a predictor of poor outcome in breast ductal carcinoma in situ (DCIS)
por: Toss, Michael S., et al.
Publicado: (2018)

Senescence-associated secretory phenotype constructed detrimental and beneficial subtypes and prognostic index for prostate cancer patients undergoing radical prostatectomy
por: Feng, Dechao, et al.
Publicado: (2023)

Stringency of the 2-His–1-Asp Active-Site Motif in Prolyl 4-Hydroxylase
por: Gorres, Kelly L., et al.
Publicado: (2009)

Suppression of a Prolyl 4 Hydroxylase Results in Delayed Abscission of Overripe Tomato Fruits
por: Perrakis, Andreas, et al.
Publicado: (2019)

Structure of transmembrane prolyl 4-hydroxylase reveals unique organization of EF and dioxygenase domains
por: Myllykoski, Matti, et al.
Publicado: (2020)

The role of HIF prolyl hydroxylases in tumour growth
por: Jokilehto, Terhi, et al.
Publicado: (2010)

Cycloheximide promotes type I collagen maturation mainly via collagen prolyl 4-hydroxylase subunit α2: Cycloheximide promotes type I collagen proline hydroxylation
por: Shi, Run, et al.
Publicado: (2022)

Natural variation in the prolyl 4-hydroxylase gene PtoP4H9 contributes to perennial stem growth in Populus
por: Xiao, Liang, et al.
Publicado: (2023)

Prolyl-4-Hydroxylase 3 (PHD3) Expression Is Downregulated during Epithelial-to-Mesenchymal Transition
por: Place, Trenton L., et al.
Publicado: (2013)

Collagen prolyl 4-hydroxylase 1 is essential for HIF-1α stabilization and TNBC chemoresistance
por: Xiong, Gaofeng, et al.
Publicado: (2018)

Inhibition of prolyl 4-hydroxylase decreases muscle fibrosis following chronic rotator cuff tear
por: Gumucio, J. P., et al.
Publicado: (2017)

Structure‐Activity Relationship and Crystallographic Studies on 4‐Hydroxypyrimidine HIF Prolyl Hydroxylase Domain Inhibitors
por: Holt‐Martyn, James P., et al.
Publicado: (2019)

Assessing the Carcinogenicity of Vadadustat, an Oral Hypoxia-Inducible Factor Prolyl-4-Hydroxylase Inhibitor, in Rodents
por: Kowalski, Heather, et al.
Publicado: (2023)

Structure and Mechanism of a Viral Collagen Prolyl Hydroxylase
por: Longbotham, James E., et al.
Publicado: (2015)

Structural Basis of Prolyl Hydroxylase Domain Inhibition by Molidustat
por: Figg, William D., et al.
Publicado: (2021)

Role of prolyl hydroxylase domain proteins in bone metabolism
por: Wolf, David, et al.
Publicado: (2022)

Bibliometric analysis of hypoxia inducible factor prolyl hydroxylase inhibitor in anemia
por: Zheng, Li, et al.
Publicado: (2022)

Caloric restriction counteracts age-dependent changes in prolyl-4-hydroxylase domain (PHD) 3 expression
por: Rohrbach, Susanne, et al.
Publicado: (2008)

Prolyl 4-hydroxylase alpha 1 protein expression risk-stratifies early stage colorectal cancer
por: Tanaka, Atsushi, et al.
Publicado: (2020)

Synergetic protective effect of remote ischemic preconditioning and prolyl 4-hydroxylase inhibition in ischemic cardiac injury
por: Yang, Juesheng, et al.
Publicado: (2022)

Effect of conjugated linoleic acid on inhibition of prolyl hydroxylase 1 in hearts of mice
por: Zhang, Jize, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_tevl7j65iclq7cnubkf40d5v5b